|
Age (years)
|
69.6 ± 7.7
|
67.8 ± 7.8
|
74.0 ± 5.6
|
0.001
|
|
Sex (male, n, %)
|
54 (66.7)
|
39 (68.4)
|
16 (66.7)
|
0.606
|
|
ACS at presentation (n, %)
|
27 (33.3)
|
19 (33.3)
|
8 (33.3)
|
1.000
|
|
CV risk profile
|
|
BMI (kg/m2)
|
30.7 ± 5.4
|
31.4 ± 5.5
|
28.9 ± 3.9
|
0.050
|
|
Waist circumference (cm)
|
107.6 ± 13.2
|
108.2 ± 14.4
|
106.3 ± 9.8
|
0.562
|
|
Hypertension (n, %)
|
70 (86.4)
|
50 (87.7)
|
20 (83.3)
|
0.599
|
|
Hyperlipidemia (n, %)
|
58 (71.6)
|
42 (73.7)
|
16 (66.7)
|
0.522
|
|
Total cholesterol (mg/dl)
|
190.0 ± 43.1
|
190.0 ± 43.1
|
190.0 ± 43.1
|
0.407
|
|
LDL-c (mg/dl)
|
117.0 ± 35.1
|
115.1 ± 34.4
|
121.7 ± 37.2
|
0.450
|
|
HDL-c (mg/dl)
|
43.3 ± 10.8
|
41.9 ± 9.5
|
46.7 ± 13.0
|
0.066
|
|
Triglycerides (mg/dl)
|
173.1 ± 75.8
|
175.9 ± 78.0
|
166.7 ± 71.6
|
0.623
|
|
Active smoking (n, %)
|
17 (21.0)
|
12 (21.1)
|
5 (20.8)
|
0.982
|
|
Pack years (py)
|
19.3 ± 21.8
|
19.5 ± 23.0
|
18.7 ± 19.1
|
0.879
|
|
Family history of CAD (n, %)
|
37 (45.7)
|
31 (54.4)
|
6 (25.0)
|
0.015
|
|
Previous CAD (n, %)
|
30 (37.0)
|
18 (31.6)
|
12 (50.0)
|
0.117
|
|
Previous PCI (n, %)
|
24 (29.6)
|
14 (24.6)
|
10 (41.7)
|
0.124
|
|
Previous CABG (n, %)
|
2 (2.5)
|
1 (1.8)
|
1 (4.2)
|
0.523
|
|
hsCRP (mg/dl)
|
13.6 ± 22.5
|
12.4 ± 23.1
|
16.6 ± 21.1
|
0.448
|
|
GFR (mg/dl/1.73 m2)
|
58.8 ± 5.2
|
59.5 ± 3.8
|
57.1 ± 7.3
|
0.136
|
|
Other comorbidities
|
|
COPD (n, %)
|
11 (13.6)
|
7 (12.3)
|
4 (16.7)
|
0.599
|
|
Diabetes severity and therapy
|
|
Diabetes duration (years)
|
11.1 ± 10.0
|
10.3 ± 9.9
|
13.1 ± 9.9
|
0.250
|
|
Diabetic polyneuropathy (n, %)
|
23 (28.4)
|
12 (21.1)
|
11 (45.8)
|
0.024
|
|
Diabetic retinopathy (n, %)
|
14 (17.3)
|
8 (14.0)
|
6 (25.0)
|
0.233
|
|
HbA1c (%)
|
7.1 ± 1.0
|
7.0 ± 1.0
|
7.3 ± 1.0
|
0.155
|
|
Insulin (n,%)
|
34 (42.0)
|
18 (31.6)
|
16 (66.7)
|
0.003
|
|
Metformin (n,%)
|
52 (64.2)
|
40 (71.4)
|
12 (50.0)
|
0.066
|
|
Sulfonylamides (n, %)
|
17 (21.0)
|
13 (22.8)
|
4 (16.7)
|
0.535
|
|
Incretins (n, %)
|
15 (18.5)
|
8 (14.0)
|
7 (29.2)
|
0.109
|
|
Other relevant medication
|
|
Aspirin (n, %)
|
77 (95.1)
|
54 (94.7)
|
23 (95.8)
|
0.835
|
|
Statin (n, %)
|
54 (66.6)
|
40 (71.4)
|
14 (58.4)
|
0.137
|
|
ACE or ARBi (n, %)
|
58 (71.6)
|
42 (76.4)
|
16 (66.7)
|
0.370
|
|
Beta-blocker (n, %)
|
62 (76.5)
|
46 (80.7)
|
16 (66.7)
|
0.173
|
